Senin, 22 September 2014

Pentagon Insider Says America on Verge of New
“Currency Crisis”

Here’s How
He’s Preparing…

Jim Rickards might be the world’s foremost expert on currencies, world economies, and the international banking system.
http://pro.stansberryresearch.com/1407TRWRCK79/LTRWQ9ZC/?h=true
 
 
*He was involved in negotiating the release of the American hostages held in Iran in 1981…
 
  *He helped the CIA investigate the stock market “tells” that preceded 9/11, when al-Qaeda associates bet against airline stocks.
 
  *And he helped the Pentagon conduct the first-ever financial “war game” at a top-secret facility a few years ago.

Today, Jim Rickards is not only a New York Times best-selling author, he still manages a hedge fund, and serves as an advisor to the Office of the Director of National Intelligence—which oversees the CIA, the NSA, and 14 other U.S. intelligence agencies.

And Rickards says right now—although few people realize it—we are on the verge of a new “currency crisis” in America.

According to Rickards…
 
“The international monetary system has already collapsed three times within the last 100 years--1914, 1939, and 1971--and another collapse would not be at all unusual. But it’s not the end of the world.”
“You just need to understand what will come next, and what the future international monetary system will look like.”
If you live in America or own any assets priced in U.S. dollars, this might be the most important financial topic in the world for you right now—which is why I’m urging you to read Jim Rickards’ new book on this subject, called The Death of Money. 
Hi, my name is Brian Hunt.

I’m the Editor in Chief of Stansberry & Associates Investment Research—the largest independent financial research firm in the world, with clients in more than 170 countries.

I publish the work of some of the smartest analysts in the world. And every year, I read dozens of financial books.

So I’m not easily impressed.

But Jim Rickards new book is crucial for EVERY AMERICAN to read as soon as possible.

It’s essentially a “playbook” for America’s next—and imminent—financial crisis.
* In fact, I like this book so much I contacted Jim and his publisher, and arranged a way for you to get a free hardback copy (you’ll pay just $4.95 to cover our costs of shipping and handling).
​ In The Death of Money, you’ll learn…
** Why paying for retirement in the future will be so much harder than it was a decade ago, and what you can do about it. (page 80)
** What government officials are planning to do PERSONALLY when the next big crisis hits. (page 63)
** Exactly how China could wage a financial war on the United States. This is a fascinating scenario every American should be familiar with. (page 44)
** How America’s greatest investor (Warren Buffett) is secretly betting against the future of the U.S. dollar. Rickards walks you through Buffett’s very large and unique investment. (page 170)
** How the U.S. dollar’s demise will take one of three (3) paths… and the one most likely to occur. (page 291)
** The strongest currency in the world right now, according to Jim Rickards. This will surprise you as it did me. (page 112)
** The investments Jim Rickards says you absolutely must own to preserve wealth in the years to come. I bet less than 1% of the U.S. population owns all of these assets on this short list right now, but you can be one of them. (page 298)
And so much more. This book is literally packed with insights and explanations regarding world currencies and America’s financial system, which I guarantee you will not find anywhere else.

Remember: You pay just $4.95 to cover shipping costs to have a hard-back copy delivered right to your front door. Normally, this book retails for $20, plus shipping.

And this deal gets even better…

The “missing chapter”…

After reading Jim Rickards new book, we called him and asked if he could write up more specific recommendations on how Americans can prepare.
The result is what we’re calling the “missing chapter,” to The Death of  Money.

This "missing chapter" is titled: How to Invest Before the Collapse. It details seven (7) specific assets Rickards recommends Americans buy right away.

For example…
 
** CURRENCIES: Rickards recommends getting some of your money out of U.S. dollars. In the “missing chapter,” he explains which currencies to buy and how to do it right here in America, without ever opening a foreign bank account.

**FINE ART: Rich people have known for generations that fine art is a great asset to own during a currency crisis. And Jim Rickards says those with the means to invest in private fund, and avoid many of the problems and pitfalls typical or art investing. Plus specifics on how to invest in precious metals, certain types of bonds, clever ways to take advantage of China, his favorite hedge funds, how to hold money in bank accounts, and more.

As you'll see, this new "missing chapter," called How to Invest Before the Collapse, is every bit as valuable as the book itself. 

And it's not available anywhere else. The only way to get it is via this special offer we've arranged with Jim and his publisher today.

                                      And there's more, too...

As I mentioned, I'm the Editor in Chief of Stansberry Research, the largest independent financial research outfit in America.
 
So I asked our own in-house currency and alternative asset expert -- a fellow named Dr. Steve Sjuggerud (pronounced sugar-rude) -- to put together his best research on the subject as well...
Dr. Sjuggerud has done an outstanding job of identifying the most recent financial crisis... and accurately predicting exactly what would happen to the markets, currencies, and the financial system in the years since then.

As Jim Rickards says, "It may be too late to save the dollar, but it is not too late to preserve wealth. And Dr. Steve Sjuggerud knows as much about the unique ways to do this as anyone you're likely to meet."

So as part of this package, you'll also receive five (5) of Dr. Sjuggerud's most important Research Reports:

 
RESEARCH REPORT #1: The Secret Currency. A unique type of currency investment that’s like gold, only better. Our readers could have made as much as 250% in recent years. It can help you grow and protect your wealth in the years to come, and unlike most gold investments, it’s very unlikely to ever be confiscated by the U.S. government. A “must-own” asset for all savvy investors.
 
 
RESEARCH REPORT #2: The Safest 7% Dividend in America. One of the disastrous side effects of our government’s currency manipulation, is that it’s now nearly impossible to earn a decent rate of interest on your savings. Well, Dr. Sjuggerud has found what might be the perfect solution—a government-related investment that should safely pay you 7% for many years to come. Everything you need to know is here. 
RESEARCH REPORT #3: How to Legally Buy Gold Bullion at a Discount to Melt Value. Here’s an ingenious way to often buy gold, via a special Canadian operation, at a big discount. The amount of the discount fluctuates. I’ve seen it as high as 6.5%. When you consider the fact that you often have to pay as much as 10% or more ABOVE the spot price, you can see how this can be a huge savings. This single idea could save you as much as $200 for every ounce of gold you want to purchase.
 
RESEARCH REPORT #4: Land Banking—America’s Safest Way to Grow and Protect Your Money. Here’s an incredible investment you can buy directly through any broker, which offers you an amazing way to buy some of the most valuable undeveloped land in America, get a great 4% dividend, and potentially make extraordinary returns. Protect your money just like the wealthy.
 
RESEARCH REPORT #5: When the End Arrives. Dr. Sjuggerud correctly identified the real estate bubble… the huge recovery that started in 2009… and the Fed-created boom that’s been going on ever since. This is why he was recently invited by one of the richest businessmen in the world to give a private presentation at the New York Stock Exchange (NYSE) headquarters on what’s going to happen next.

And now, Dr. Sjuggerud believes he knows exactly when things will start to change dramatically in the U.S. financial system. He even gives an exact day it could all start, based on historical precedent. What will this mean for stocks, bonds, real estate, commodities, and precious metals? What should you own, what should you avoid, and how soon will this all start? Dr. Sjuggerud explains everything you need to know in this brand-new, just-published report.

This might be the most important information you read over the next five years… and remember, you can claim a copy, free of charge.

You can take advantage of this special offer when you claim a free 30-day trial subscription to Dr. Sjuggerud’s monthly research newsletter, called True Wealth.

On the third Friday of every month, Dr. Sjuggerud updates you on the currency situation, the unintended consequences of the Fed’s money printing, and explains new and unique “alternatives” to protecting and growing your money.

It’s the perfect way to stay up-to-date on the currency crisis taking place in America right now.

To sum up: For just a $4.95 shipping charge today, you’ll receive:
 
** A hardback copy of Jim Rickards’ great new book: The Death of Money. Your $4.95 shipping and handling payment is all you’re responsible for when you choose to get this great new hardback booked delivered to your front door.
 
** The “missing chapter” from Rickards’ new book, called How to Invest Before the Collapse. This includes the specific details on 7 of Rickards’ favorite investment ideas to protect yourself and perhaps even profit in this looming crisis.
 
** Five (5) Research Reports from our in-house currency expert, Dr. Steve Sjuggerud:


#1 The Secret Currency.
#2 The Safest 7% Dividend in America.
#3 How to Legally Buy Gold Bullion at a Discount to Melt Value.
#4 Land Banking—America’s Safest Way to Grow and Protect Your Money.
#5 When the End Arrives.

 
** A free 30-day trial to Dr. Steve Sjuggerud’s True Wealth monthly newsletter. New issues are delivered on the third Friday of every month.


Why are we offering this incredible package, so cheap?

We look at it this way…

Our Baltimore-based firm does the best financial research in the business.

And today, we want to introduce you to the work we do, with the hope that you might want to do business with us in the future.

But we know that rather than TELLING you about our work… the best way explain our business is to simply SHOW you what we do, with essentially a free sample—and no obligation for you to ever purchase anything from us ever again.

That’s why we’re happy to send you this full package for just a $4.95 shipping charge.

If you like our work, great—we hope you’ll keep reading Dr. Sjuggerud’s True Wealth, or maybe one of our other publications. If not, no problem, just let us know and you’ll never pay us another penny.

We’ve ordered a small and limited number of Jim Rickards’ new books, so if you are interested, please act soon.

And I know this special package, available for a shipping charge of just $4.95, will not be available for long.
 
Get started today by clicking on the Order Now button below.

This takes you to a secure Order Form page, where you can review all the specifics of this offer once more, and enter the details on where you’d like your book and research sent.

Keep in mind: You’ll receive Jim Rickards’ “missing chapter” and all of Dr. Sjuggerud’s work, sent to you electronically, in a matter of minutes after placing your order.

A hardback copy of Jim Rickards’ new book will arrive on your doorstep, soon after.

Good investing,

Brian Hunt
Editor in Chief, Stansberry Research
June 2014

Montel’s Miracle
After suffering from one of the world’s most dreaded diseases
This TV celebrity came across a life-changing miracle cure.
It’s a tiny device transforming all brain treatments...
While handing early investors 293 times their money.
(INSIDE: Rare interview with Montel Williams)

Dear Reader,
Hi, Nick Hodge here.
As an investment analyst, I get to meet all kinds of people — CEOs, engineers, scientists, and even celebrities.
Recently, I sat down for an interview with former daytime talk show host Montel Williams.
Why? Because the newest investment opportunity I’ve been researching for my readers involves a groundbreaking medical device...
A device that promises to forever change how we treat and cure brain diseases...
A device that could improve — and extend — millions of lives... and make early investors ultra wealthy in the process.
Montel Williams is one of the patients using this device, which was created by a group of Wisconsin scientists. He first read about it in a magazine article on an airplane.
He agreed to personally share his experience with me in an on-camera interview. The CEO of the tiny company behind the device joined us, too.
You won’t believe what it did for Montel...
You see, back in 1999, Montel was diagnosed with one of the world’s most dreaded diseases.
It's a debilitating disease that attacks the brain’s nerve cells, resulting in impaired memory, thinking, and behavior.
Every single hour, somebody in the world is diagnosed with it.
Montel has multiple sclerosis.
I asked him to describe his condition when he began using the device...


Montel couldn’t even walk properly before he began using this device. Even though his doctor told him it would never work, Montel went to Wisconsin to try it anyway.
But he was skeptical... He’s tried every treatment out there — including a deadly, invasive form of surgery to the veins in his head called "roto-rootering"...


This groundbreaking new treatment doesn’t involve any pill regimens...
Any invasive surgeries...
Or any agonizing therapies.
It involves a tiny oral device designed to stimulate certain nerves in your brain through your tongue.
This nerve stimulation helps treat brain disease in a way that’s never been done before.
All the science shows it helps the brain to heal itself.
This therapy is pain-free, easy, and quick — the typical session with a patient lasts about 20 minutes.
The device is portable, too, so patients can take it anywhere they go.
It may sound like science fiction... but the results are nothing short of spectacular. I even asked Montel what his doctor says after telling him it would never work.


Even more incredible was when he showed me how it improved his balance...


As you can see, it’s been an emotional journey for Montel — especially considering he could barely stand before he started using the device four years ago.
Now, Montel can jog on a treadmill. He’s swimming on his own and even heli-boarding.
After 10 years of chronic and intense pain, this device is giving Montel his life back.
And now it’s giving new hope to the 8.8 million people suffering worldwide from multiple sclerosis who are desperately searching for a way to get their lives back.
As Popular Science writes:
ea-neurohabilitation-tearsheet
Yet Montel’s miraculous story is merely the tip of the iceberg when it comes to what this incredible device is capable of.
It could be used to treat — and cure — a wide range of brain diseases including Parkinson’s, traumatic brain injury, and even Alzheimer’s.
And it could make savvy early investors downright RICH.
Better still, the U.S. Army has partnered with the company that created this groundbreaking technology.
The Army is completely funding the FDA clinical trials for the company’s tiny, life-changing device.
And it could become one of the biggest medical stories of the century.
So why exactly is the U.S. Army so interested in this innovative device?
What does the tongue have to do with curing brain disease?
And who is the group of scientists behind this breakthrough medical technology that’s giving hope to millions of patients like Montel?
I’ll reveal the groundbreaking details to you today in this brief presentation, including how you could seize this rare opportunity for extraordinary wealth.
But here’s the thing: Like all truly life-changing medical discoveries, timing is critical.
In order to reap the biggest rewards from this medical advancement, you’ll need to act on this BEFORE results from FDA trials break...
And BEFORE the company’s share price — which is currently trading around $3.00 — takes off like a surface-to-air missile.
You’ll need to move quickly.
So let’s get straight to it...

Army-Approved
The device has caught the attention of the U.S. Army.
The Army is so interested in this promising technology that it is funding the FDA approval process and even using its facilities and personnel for the trials.
In other words, it’s putting up ALL THE MONEY for clinical trials so the company behind this medical breakthrough doesn’t have to.
This is HUGE because it is a very expensive process. The cost is roughly $38.5 million!
That’s how much faith the Army has in this company’s revolutionary device... and its incredible healing power.
Why exactly are they doing this?
Let me explain...
Say an American soldier takes a blow to the head from a roadside blast in combat... and suffers a traumatic brain injury.

Because of this injury, the soldier is no longer the same. He has trouble functioning normally, and he can barely walk.
When the soldier returns home from combat, his family is devastated.
The soldier can't play baseball with his son or take his daughter to the park. He can’t even do everyday activities like getting dressed or eating on his own.
It’s a sad reality too many American families are living with.
According to the Pentagon, there are more than 600,000 American soldiers suffering from traumatic brain injury symptoms.
Now imagine there was a way for these soldiers to be healed quickly, painlessly, and naturally...
The incredible device I’ve been telling you about today could be the answer the Army is looking for.
Just take the story of Gerry Hooper...
Gerry was a happy, active 53-year-old woman.
She liked to go trail running in the fields near her home with her dog and spend time with her loved ones.
But five years ago, tragedy struck when Gerry was injured in a car accident.
She suffered traumatic brain injury. She couldn’t walk properly. And she was told by doctors her life was never going to be the same.
This device was her last hope. Here’s footage of her incredible experience...


The device gave Gerry her life back.
And now the Army wants to harness this technology to treat soldiers and civilians who suffer brain trauma, which can impair a patient’s memory, coordination, and balance.
Just a few treatments could save veterans from a lifetime of brain injury and allow them to quickly return to their normal, healthy lives.
As Popular Science writes, "At a time when soldiers are likelier than ever to survive a battlefield injury, this tongue-to-brain device offers a glimpse at the kind of medical care veterans will need for decades to come."
The California Medical Instrumentation Association says, "The device could be a game-changer for those suffering from brain trauma."
Montel Williams, who graduated from the Naval Academy and served in the Marine Corps, also recognized the potential it had for American soldiers.
In fact, Montel was the person who introduced the device to the Army!


In February 2013, the Army signed a contract with this company, and the rest is history.
ea-neurohabilitation-montel-army
You simply couldn’t ask for a better partner than the U.S. Army. They're committed to getting this device approved and are bearing the brunt of the costs to do so. It’s a privilege other biotech companies simply don’t get.
Traumatic brain injury costs Americans a stunning $48 BILLION a year.
And this tiny company could not only provide relief for millions... it could also DOMINATE this market and make savvy investors wealthy in the process.
Yet the Army knows that treating brain trauma is just the beginning of what this incredible device could do for both soldiers and civilians.
It could be used to treat — and cure — a wide range of insidious brain diseases.
It can bring hope to people all over the world suffering from Parkinson’s, multiple sclerosis, stroke, and even Alzheimer’s.
And it could give savvy investors — who get in right now — a shot at enormous wealth.
I’ll tell you how you could claim your share in just a moment.
Right now, let me share with you some more details about this cutting-edge technology...

What Makes This Medical
Device So Unique?
Earlier, I told you this device doesn’t involve any invasive surgeries or agonizing therapies.
Instead, it uses your tongue to help the brain heal itself.
I know that may sound a bit weird. So let me explain...
The tongue is an amazing organ.
After all, you couldn’t savor your favorite meal without it... or talk about how much you enjoyed it.
Yet perhaps one of the tongue’s most exciting roles is that it serves as a direct "gateway" to the brain.
And this could be the key to treating a wide range of brain diseases.
See, there are thousands of tiny nerves on the tongue that connect to the brain.
This group of Wisconsin scientists discovered that these nerves could help restore lost physical and mental function.
So they created a miniature device you place on a patient’s tongue that sends specially patterned impulses to the brain.
The patient bites down on the device while performing a 20-minute series of specially designed physical and mental exercises for his or her symptoms.
This stimulation therapy works to repair the damaged areas of the brain.
What makes this treatment so unique is that it doesn’t just target one specific brain disease but symptoms of multiple diseases.
The company’s CEO explains how...


In short, the device has been designed to treat the symptoms of a wide range of diseases. So it doesn’t matter which brain disease is actually causing them.
And not only does the device prevent the loss of mental and physical functions like balance and walking in patients, but it also RESTORES these lost functions.
It helps patients to perform these functions better than they could while dealing with the disease.
No other treatment on the market can both stop the progression of the debilitating symptoms of brain disease AND reverse them!
The company has three patents pending on this breakthrough technology. So it can’t be copied.
And the results of this medical marvel have been nothing short of magical...

A Broadway Star's
Incredible Breakthrough
You probably haven't heard of a man named Ron Husmann.
He was an up-and-coming mega-sensation on Broadway.
ron-hussman-broadway
He performed alongside stars like Carol Burnett, Hal Prince, Ethel Merman, Bernadette Peters, and Debbie Reynolds. He even won a Tony. His career was soaring.
But in 1981, his life took a drastic turn when he was diagnosed with multiple sclerosis.
He began losing his voice that same year. Even a microphone couldn’t help him.
Whispers and silence soon followed.
His livelihood and the talent that had given his life so much meaning were gone.
Soon, he began losing his balance. The disease left him unable to walk a straight line or turn easily even with a cane.
Ron’s family was desperate to find something... anything... that would slow down — let alone reverse — his increasingly debilitating symptoms.
That’s when they stumbled across a pilot study by a group of Wisconsin scientists.
They were seeking volunteers to test the effects of a new device on multiple sclerosis symptoms.
Ron signed up and was accepted into the study. And that’s when his incredible road to recovery began.
He could barely walk when he arrived at the scientists’ tiny lab in Wisconsin. He couldn't sing a note.
But after his fourth session using this device — just 80 minutes! — Ron burst into tears.
"It was a shock. I could sing," Ron said. "It was the first time I could sing a whole song in 30 years. I had a complete breakdown. They stood there and stared at me, while I just sobbed."
After 27 years of whispers and silence, Ron cannot only talk again, but he can sing.
He’s now even able to take part in everyday activities.
"I feel free. I can walk the dog. I don’t have to worry about falling over, and I always felt like I was going to tip over sideways. The biggest part is I can talk," says Ron.
Amazing...
After all, if you knew this device could repair your spouse’s brain or that of a loved one, wouldn’t you put up the money for it?
Of course you would... I would too. We all would...
In North America alone, there are over 140 million people suffering from brain disorders that this device can treat.
These disorders cost the U.S. a whopping $950 BILLION!
So this company has the potential to capture several billion dollars’ worth of sales.

And that's only part of
what this device can do...
Let me explain...
In the same way this device helps patients suffering from traumatic brain injury, it can also be used to help people who experience less severe injuries.
I’m talking about bringing relief to people who get concussions when playing sports or people who are injured in car accidents.
And it gets even better still...
See, while the device is nothing short of a miracle for people suffering from diseases, it could also have incredible applications for people who don’t have brain disorders.
It could eventually be used as a brainpower "booster."
What does that mean exactly? Let me give you an example...
The company’s CEO uses it while playing brain games on the computer and has seen improved performance.
People can use it while they’re studying. Athletes can use it to hone their skills. You can use it to improve your golf swing.
In short, you can essentially apply it to ANY of your activities you want to improve.
How exciting is that?
JUST THINK OF THE INVESTMENT POTENTIAL...
In short, this device could essentially be used by EVERYONE on the planet.
Currently, the company is forecasting $100 million in sales by 2018 and $140 million by 2019.
But these are EXTREMELY conservative estimates.
Why? Because they are only based on the market for traumatic brain injury. These figures don’t even account for multiple sclerosis, Parkinson’s disease, or Alzheimer’s.


Remember, there are 140 million people with brain disorders in North America alone that can be helped by this device...
Disorders that have a combined cost of $950 BILLION.
It gets even more mind-boggling when you think about all of the potential uses it has for people who don’t have brain diseases.
This is the kind of opportunity that can drastically change your financial future...
An opportunity for you to get in on the ground floor of a transformational technology that could not only help mankind overcome many of its most dreaded diseases...
But also make you a RICH TYCOON with the opportunity to control your own destiny.
This is the kind of wealth that fuels the "good life"... and could provide a financially secure retirement for you and your loved ones.
Sound too good to be true?

It's Happened Before With
Transformational Medical Technologies
Fact is, history has shown that when a tiny biotech company hits upon a true breakthrough discovery... savvy early investors get rich.
Might as well be you this time...
Just have a look at some of these prior examples...
ea-neurohabilitation-vanda
  • 1,349% in a single month
    When biotech innovator Vanda Pharmaceuticals released its game-changing schizophrenia drug Fanapt, investors watched as their shares soared 1,349% in less than a month.
ea-neurohabilitation-incyte
  • 5,578%
    Incyte Corporation developed a drug called Jakafi to treat a rare and deadly blood disease. The stock rocketed from $2.25 a share to over $130. That's good enough to turn $25,000 into over $1.4 million.
ea-neurohabilitation-novo
  • 4,298%
    Novo Nordisk specialized in diabetic care and brought the drugs NovoNorm and PrandiMet to the market, as well as the groundbreaking diabetic drug Victoza, which brought in $2.7 billion. Its stock returned a life-changing 4,298%.
ea-neurohabilitation-biogen
  • 76,567%
    Biogen Idec blazed a trail by launching the first multiple sclerosis drug, Avonex, which achieved $1 billion in sales. No surprise the investors cashed in a staggering 76,567% gain — turning a tiny $2,000 into a whopping $1.53 million.
As you can see, we’re talking anywhere from 13 to 766 times your money.
This tiny biotech is set to join the rare ranks of history-making biotechnology companies that have discovered world-changing medical advances.
And its discovery is at the forefront of a new approach to treating ALL brain diseases...
Not to mention the wide array of applications it has beyond treating brain disease.
Better still, the U.S. Army has partnered with this tiny company to help bring the device to the market. It is completely funding the FDA clinical trials — a massive advantage for this little company.
Plus, one of the company’s founders has helped bring several medical devices to the market for billion-dollar pharmaceutical giants including Pfizer and Bristol-Myers.
That’s one-of-a-kind industry expertise you can bank on.

So why haven't you heard
about this story yet?
Well, it’s probably because this company is TINY. In fact, it’s still only a micro cap, or what some would call a penny stock. It’s trading right now for under $3.00 a share.
But that could change when it passes through FDA trials with the Army's assistance...
Just look at what happened to medical device company Stereotaxis. It received an FDA clearance for one of its medical devices on July 29 of last year.
In less than a week, the stock shot from $1.62 a share to $9.24. That’s a huge 469% return in about six days!
ea-neurohabilitation-stereoaxis
Or consider a company called Cyberonics. It received FDA clearance for a similar medical device that treats epilepsy...
Since getting FDA approval for the device, Cyberonics’ stock is up 342%.
ea-neurohabilitation-cyberonics
That’s why you’ll want to get in now... BEFORE the company’s device passes FDA trials and mainstream investors send the stock soaring by many multiples.
But there is yet another way you could cash in on this tiny, life-changing company.

See, tiny biotech firms are fast becoming takeover targets for pharmaceutical giants.

The reason is simple: the partnerships make sense. Biotechs need cash infusions to bring their products to market; pharmaceutical companies need more products in their pipelines.

Perfect example: In January 2012, Bristol-Myers Squibb bought out small biotech Inhibitex for $2.5 billion.

The market cap for Inhibitex doubled in a flash. Its stock rose from a low of $2.33 in October 2011 to $26 in February 2012.
ea-neurohabilitation-inhibitex
Shareholders made a killing... 1,016% gains in four months.
So even if this stock I’ve been telling you about gets bought out, you could still make a retirement fortune.

The opportunity for early wealth builders is astronomical...
In just a moment, I’ll tell you how to secure your FREE copy of a timely new report I’ve put together on this new breakthrough. It’s called "Montel's Miracle: The Brain Device Money Multiplier."
You'll also learn the ticker symbol and up to what price to buy this little gem.
But first, let me share with you a bit more about myself...

Your Inside Guide
As I mentioned, my name is Nick Hodge. Nick Hodge
I’m the editor of Early Advantage, the resource for big profits from little-known breakthroughs and disruptive technologies in energy, electronics, biotech, and more.
My insights have led to numerous appearances on television and in various outlets on the Web — including the Business News Network and Yahoo! Finance's Daily Ticker...
Perhaps you’ve read one of my best-selling books on energy investing, like Investing in Renewable Energy: Making Money on Green Chip Stocks or Energy Investing for Dummies...
Or maybe you've seen me speak at numerous investment conferences around the country.
My goal at any appearance is always the same: to bring you the latest information, ideas, and companies that could change your life... and bring you enormous gains.
Like they did for these readers:
I’m a Subscriber for Life
ea-neurohabilitation-quote1
Retiring a Multi-Millionaire!
ea-neurohabilitation-quote2
Up 100% On the Year

ea-neurohabilitation-quote3
Transformed My Lifestyle
ea-neurohabilitation-quote4
Account is over $450,000!!!
ea-neurohabilitation-quote5
My goal is to get you in on the ground floor of emerging technologies, like this tiny oral device for treating brain disease, so you can maximize your gains before the Wall Street fat cats jump on board.
What I've been telling you about today is such a monster medical breakthrough that even the U.S. Army has climbed on board.
And it’s sponsoring this little company through its FDA approval process.
The device has the revolutionary power to not only stop brain diseases dead in their tracks but also REVERSE their effects... easily, quickly, and without pain!
For millions of patients suffering around the world, this device is potentially life changing.
And for early investors in the company behind the device, it could be the single best financial move you’ll ever make.montel-report
That's why I've prepared a research report explaining the details in full...
It’s called, "Montel's Miracle: The Brain Device Money Multiplier."
Even better, I’d like to give you access to this research free of charge.

It’s the first thing you’ll receive when you take an entirely risk-free trial subscription to my research service, Early Advantage.

But before you decide if my work is right for you, let me show you something else I’ve spent an extraordinary amount of time investigating in recent months...

A Cancer Cure So Secret, It's
Locked Inside a U.S. Naval Base
I recently flew to the West Coast to vet a tiny, unheard-of biotech firm.
Their operation is so secret that they work out of a naval base. There are armed guards at the gates. I had to send my credentials ahead of time to get clearance for entry.
That’s because this company holds the key to freeing human beings from breast, prostate, lung, lymphoma, leukemia, and brain cancer...
It could free us from Alzheimer's, arthritis, and heart disease... from nursing homes and the indignities of old age.
This tiny company — trading right now for $2.00 a share — controls the world’s only source of a cancer-curing chemical.
This rare chemical is called "Blue Blood."
This highly rich "Blue Blood" Protein — which really is blue — is extracted from one of the rarest and most endangered animals on the face of this planet... a sea snail called a limpet.
What makes this blood so unique and life changing?
Well, it's a major component of over 100 vaccines and drugs currently going through clinical trials with the FDA. In other words, these drugs simply cannot work without "Blue Blood"... and there is nothing in the world that can replace it.
And here's the mind-blowing peculiarity in all of this...
"Blue Blood" is so vital to breakthrough vaccines and drugs today... one gram of it can sell for up to $900,000.
Talk about top dollar!
The biggest pharmaceutical companies around the world don't mind paying a fortune for it.
Why?
Well, because right now, "Several companies and institutions are developing Blue Blood based therapies for a wide variety of cancers," according to the National Cancer Institute.
If you're thinking of American giants like Pfizer, Merck, Amgen, and Biogen Idec... you wouldn't be off the mark.
England's GlaxoSmithKline, Germany's Bayer, Switzerland's Novartis, and Denmark's Novo Nordisk all need this "Blue Blood" too...
And the most exciting part of this opportunity for you is that they can only get this "Blue Blood" Protein from one little biotech company.
It owns exclusive rights and patents to grow the limpets and extract their blood without killing them... which gives this little gem a virtual monopoly in the biotech arena.
Over the last seven months, I've been shouting about and making the call on this little company — and it's been up as much as 300% since then.
Now, I'm predicting the stock could surge another 300% over the next 12 months based on events already shaping up. A deal with a company developing a breast cancer vaccine has already been signed.
I suggest you get in now to avoid missing out again on this life-changing opportunity.magic-molecule-report
Remember, it's trading below $2 right now. So there isn't much time to waste. You need to get in now to reap the biggest possible gains.
If this sounds like something that interests you, then I'm ready to send you my free report on this situation: "Minting Millions from the Magic Molecule."
All I ask in return is that you take a risk-free trial membership to my research publication Early Advantage.
What exactly is Early Advantage... and how can it make you rich from groundbreaking investment research?

I Spend Millions on My Research
You already know the best way to make a lot of money is to get in the game early — before a company makes news with a major discovery in the mining or energy sector... the creation of some disruptive technology... or breakthroughs in agriculture or medicine.
It's the reason I meet with start-up CEOs in Silicon Valley... visit actual farmers... inspect mines in Alberta and Ontario... attend obscure conferences and trade shows... and conduct private, one-on-one interviews just like the one I had with Montel Williams.
It's all in the name of giving you the early advantage on any moneymaking or money-saving opportunity available — long before the rest of the market catches on.
That's what Early Advantage is all about.
I've been on the cutting edge for years, discovering major life-changing, moneymaking opportunities that other financial institutions don't cover.
For example...
  • Before 3D printing made the news, I told my readers about a company called Organovo that develops three-dimensional (3D) human tissue printing technology to create tissue on demand for research and surgical applications. Since then, the stock has surged over 570%.
  • Then there's Natcore Technology, a company with a number of patented technologies that any solar company can use to double the efficiency of current solar cells while cutting costs in half. I flew to New York to visit the company's facilities and was impressed with what I saw. In less than three months, my readers were able to secure a 128% gain.
Quite often, my investigations lead me to companies that you may never hear or read about in mainstream news publications like the Wall Street Journal or Forbes...
But that's okay with me... the gains for my readers are real — no matter how many mainstream publications ignore the opportunities.
If the stock is everywhere, there is no way you'll ever make any money on it. But that's what's great about my approach, and it has rewarded my readers handsomely.
Benny J. called in to say:
ea-neurohabilitation-quote6
Anthony R. also shared his experience:
ea-neurohabilitation-quote7
Rest assured, these are the opportunities that can make you rich in the game. And that's my sole purpose here.
In short, that's the work I do on behalf of my readers, and it's made them a lot of money and the most satisfied in the investment business.
I've closed, in total, more than 210 double- and triple-digit winners on my stock recommendations alone by locating little-known wealth-building opportunities before the masses knew about them.
Here’s just a snapshot...
  • 159% on Xethanol Inc. (in 3 months)
  • 119% on Cree
  • 316% on Akeena Solar
  • 101% on JA Solar
  • 426% on Alternate Energy Holdings (in just 3 months)
  • 110% on Solarfun Power
  • 391% on BYD Company (in 3 months)
  • 73% on World Energy Solutions (2 days)
  • 62% on Maxwell Technologies (3 months)
  • 82% on Capstone Turbine (7 months)
  • 78% on PowerSave Energy (3 months)
  • And many more!
There are just too many great opportunities hidden in the market making great gains for everyday investors... while you sit on the sidelines.
As activity heats up in the biotech space and the masses catch onto this story, expect late investors to push the price through the roof.
I want you in before this happens, and I'll help make this decision easy for you right now...

Below is a List of What You'll Get
I’d like to send you free copies of my two new reports:
Research Report #1: "Montel's Miracle: The Brain Device Money Multiplier"
Research Report #2: "Minting Millions from the Magic Molecule"
These two reports will be the first things you should read when you take a no-risk trial of my research advisory, Early Advantage.
Because of the urgency of these plays, you'll have access to that info minutes after you sign up. But that's not all you'll get.
You'll also have full access to...
  • Quick Profits E-alerts: Get flash updates on the latest moneymaking scoops from my profit alerts. These obscure recommendations — that cannot wait a minute — will be delivered straight to your inbox seconds after they're written, as profitable opportunities could surface tomorrow.
  • Regular Portfolio Updates: You'll know exactly what's happening with each profit-making play in your model portfolio, including regular updates and any news that will send the stock soaring further or when to sell for maximum profits.
  • The Members-Only Early Advantage Website: Your gateway to my secure online platform for members only, with my no-nonsense research reports, commentary, picks, and current portfolio. You'll even get fast-track commentary on how to get the most out of my service.
  • Research Videos: You'll have full access to my "boots-on-the-ground" research videos when I travel around the country investigating companies, visiting their facilities, and talking to CEOs. That way, you can follow my travels from your living room.
Within minutes of signing up, you'll receive an email with your password to the Early Advantage website... your ultimate gateway to unheard-of profits in cutting-edge sectors ahead of the crowd.
I encourage you to read the research reports you'll see there. Many of the recommendations are still considered major "buys."
Be sure to scan the "Getting Started" window to learn how to get the most out of this service.
Given all that, at this point you must be asking...

So How Much Does
Early Advantage Cost?
I don't have to tell you how much it costs to uncover the kind of information I do.
One minute, I am jetting to California to check out the latest in breakthrough biotech. Next minute, I'm hopping a plane to Ottawa or landing in a floatplane on a lake in Saskatchewan.
This is by no means a cheap operation. But it's worth the research.
Plus, a higher price tag helps keep this group small. I know this probably seems contrary to our business interests, but we don’t want a lot of people piling into Early Advantage. 

Why?

Because we’re dealing with some of the smallest and most illiquid stocks in the market. If too many people try to get in on these deals, the share price will fly through the roof, and the opportunity will be ruined.
No doubt the money you'll make from my picks will always be several times what you pay for my research.
Consider this: One of my readers, Peter H., recently said,
ea-neurohabilitation-quote8
Another of my followers, who wishes to remain anonymous, chimed in,
ea-neurohabilitation-quote9
In fact, the profits from one recommendation alone could pay for your subscription several times over. Just how much does it cost?
One full year of Early Advantage is only $799.ea-neurohabilitation-quoteside
This price takes you into our profitable world of investing and gives you full access to all my research, including the small company’s Army-funded oral device I’ve been telling you about.
You'll get full details on how this tiny company is revolutionizing the way brain diseases are treated... and how it can make you several times your cash.

Join Early Advantage

Without Taking Any Risk
Best of all, you can access this research with no risk whatsoever. Here's what I mean...
As soon as you join Early Advantage today, you'll be able to access your free reports, "Montel's Miracle: The Brain Device Money Multiplier" and "Minting Millions from the Magic Molecule."
I am confident this research will put profits in your pocket.
Take the next 60 days to soak in my research. Comb the Early Advantage website. Look at my track record. There are even archives of reports and issues you can skim through at any time.
Put some money into some of my open recommendations. Many are still "buys."
Everything is just waiting there for you.
During your 60-day trial period, if you're not completely satisfied with my research... or if you don't think you can prosper financially through my recommendations...
Simply let me know, and I'll refund every cent. No hard feelings, and no line of questioning — you'll receive all your money back immediately.
You can even keep your free report and any other piece of intelligence you get... regardless of what you do.
Your free report spells out all you need to know to take full advantage of this brain disease-crushing biotech opportunity immediately.
This firm is transforming how brain disease is treated with its breakthrough medical device...


And you can take advantage of this unique opportunity with absolutely no risk. Either you're satisfied, or your money back.
But please hurry: Because the stocks I recommend are small-cap stocks, too many readers can push up the share prices and adversely affect your profit potential. So we really must limit membership to Early Advantage.
If you’re late to respond to this invitation, your name goes on a wait list with potentially thousands of other readers... That’s why I urge you to subscribe right now if this is something you’re interested in.
To access your report and all my other research, please start your membership now.
I look forward to the profits we'll make together.
Good Investing,
Nick Hodge Signature
Nick Hodge
Editor and Creator, Early Advantage

Tidak ada komentar:

Poskan Komentar